Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 30, 2015 12:52 AM ET

Healthcare Providers and Services

Company Overview of VITAS Healthcare Corporation

Company Overview

VITAS Healthcare Corporation provides hospice and palliative care services for adult and pediatric patients with life-limiting illnesses in the United States. Its hospice services include pain and symptom management, and emotional and spiritual support for patients, as well as bereavement support for families. The company’s services also comprise routine home care, general inpatient care, continuous home care, and respite care services. It offers a range of life-limiting illnesses services, including cancer, stroke, heart disease, lung disease, liver disease, kidney disease, multiple sclerosis, ALS, Alzheimer’s, and AIDS. The company provides hospice care services in patients’ homes; in its ...

201 South Biscayne Boulevard

Suite 400

Miami, FL 33131

United States

Founded in 1978

Phone:

305-374-4143

Key Executives for VITAS Healthcare Corporation

Chief Executive Officer
Age: 58
President and Chief Financial Officer
Age: 54
Senior Vice President of Operations
Chairman, Chairman of Chemed Corporation, President of Chemed Corporation, Chief Executive Officer of Chemed Corporation and Director of Chemed Corporation
Age: 60
Senior Vice President and General Counsel
Age: 60
Compensation as of Fiscal Year 2014.

VITAS Healthcare Corporation Key Developments

VITAS Healthcare Corporation Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Full Year 2015

VITAS Healthcare Corporation announced unaudited earnings results for the first quarter ended March 31, 2015. For the year, the company’s service revenues and sales was $269.613 million in the first quarter of 2015, which is an increase of $9.2 million, or 3.5%, when compared to $260.412 million for the prior-year period. This revenue increase is comprised of an average Medicare reimbursement rate increase of approximately 1.4%, a 3.5% increase in average daily census, offset by the impact of the estimated Medicare Cap billing limitation in 2015 when compared to the prior year. Income from operations was $30.195 million against $28.273 million a year ago. Income before income taxes was $31.431 million against $29.268 million a year ago. Net income was $19.315 million against $18.159 million a year ago. Adjusted EBITDA, excluding Medicare Cap, totaled $35.954 million in the quarter, an increase of 8.2% over $33.939 million for the prior-year period. EBITDA was $36.440 million against $34.357 million a year ago. For the full-year 2015, the company’s revenue growth for VITAS, prior to Medicare Cap, is estimated to be in the range of 3% to 4%. Admissions in 2015 are estimated to increase 4% and full-year Adjusted EBITDA margin, prior to Medicare Cap, is estimated to be 14% to 15%. Medicare Cap billing limitations for calendar year 2015 are estimated to be $4.3 million.

VITAS Healthcare Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for the Full-Year 2014

VITAS Healthcare Corporation reported earnings results for the third quarter and nine months ended September 30, 2014. Net revenue was $265 million in the third quarter of 2014, which is an increase of $11.4 million, or 4.5%, when compared to the prior-year period of $254 million. This revenue increase is comprised of an average Medicare reimbursement rate increase of 1.4% and a 2.8% increase in average daily census. Net income was $21,593,000 compared to $14,608,000 a year ago. Adjusted EBITDA was $38,339,000 compared to $37,314,000 a year ago. Income from operations was $33,320,000, compared to $22,394,000 a year ago. Income before income taxes was $34,736,000, compared to $23,650,000 a year ago. For the nine months, total revenue was $789.822 million, compared to $788.896 million a year ago. Net income was $60,645,000 compared to $55,237,000 a year ago. Adjusted EBITDA was $109,756,000 compared to $112,567,000 a year ago. Income from operations was $94,030,000, compared to $85,615,000 a year ago. Income before income taxes was $97,806,000, compared to $89,288,000 a year ago. Full-year 2014 revenue growth, prior to Medicare Cap, is estimated to be in the range of 1% to 2%. Admissions in 2014 are estimated to increase 2% and full-year adjusted EBITDA margin, prior to Medicare Cap, is estimated to be 14.5% to 15.0%.

VITAS Healthcare Corporation Announces Unaudited Financial Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Second Quarter, First Half and Full Year of 2014

VITAS Healthcare Corporation announced unaudited financial results for the first quarter ended March 31, 2014. For the quarter, the company reported service revenues and sales of $260.412 million against $271.326 million a year ago. Income from operations was $28.273 million against $31.557 million a year ago. Income before income taxes was $29.268 million against $32.575 million a year ago. Net income was $18.159 million against $20.142 million a year ago. EBITDA was $34.357 million against $37.626 million a year ago. Adjusted EBITDA was $33.939 million against $37.577 million a year ago. VITAS estimates its revenue growth will be constrained in the first half of 2014. This is primarily the result of the 2.0% Medicare rate cut implemented in the second quarter of 2013 as well as continued mix shift from high acuity care to routine home care. These factors will negatively impact revenue comparisons in the first half of 2014. Full-year 2014 revenue growth for VITAS, prior to Medicare Cap, is estimated to be in the range of 1% to 3%. Admissions in 2014 are estimated to increase 3% to 4% and full-year adjusted EBITDA margin, prior to Medicare Cap, is estimated to be 14.5% to 15.0%. Medicare Cap is estimated to be $5 million in 2014. Revenue, adjusted EBITDA and admissions growth is anticipated to begin in the second quarter of 2014, with the majority of this growth weighted to the second half of 2014.

Similar Private Companies By Industry

Company Name Region
Select Specialty Hospital-Savannah, Inc. United States
Primary Medical, LLC United States
The Greeley Medical Clinic, P.C. United States
Liberty HealthCare System, Inc. United States
Eye Centers Of Florida, P.A. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VITAS Healthcare Corporation, please visit www.vitas.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.